By expenditures
| Name | Title | Type |
|---|---|---|
| Grace Austin | CFO | Auditee |
| Frank Miceli | Principal | Auditee |
| Michael Riso | Chief Financial Officer | Auditee |
| Melanie Ballestas | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 365451 | 2024 | 2025-09-03 | Baker Tilly | $9.34M |
| 321699 | 2023 | 2024-09-27 | Cliftonlarsonallen LLP | $12.14M |
| 16999 | 2022 | 2023-09-05 | Cliftonlarsonallen LLP | $10.28M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 365451 | 2024 | 2025-09-03 | 1151848 | 2024-004 | Significant Deficiency | - | L |
| 365451 | 2024 | 2025-09-03 | 1151847 | 2024-004 | Significant Deficiency | - | L |
| 365451 | 2024 | 2025-09-03 | 1151846 | 2024-004 | Significant Deficiency | - | L |
| 365451 | 2024 | 2025-09-03 | 1151845 | 2024-004 | Significant Deficiency | - | L |
| 365451 | 2024 | 2025-09-03 | 1151844 | 2024-004 | Significant Deficiency | - | L |
| 365451 | 2024 | 2025-09-03 | 1151843 | 2024-003 | Significant Deficiency | Yes | I |
| 365451 | 2024 | 2025-09-03 | 1151842 | 2024-003 | Significant Deficiency | Yes | I |
| 365451 | 2024 | 2025-09-03 | 1151841 | 2024-003 | Significant Deficiency | Yes | I |
| 365451 | 2024 | 2025-09-03 | 1151840 | 2024-003 | Significant Deficiency | Yes | I |
| 365451 | 2024 | 2025-09-03 | 1151839 | 2024-003 | Significant Deficiency | Yes | I |
| 365451 | 2024 | 2025-09-03 | 575406 | 2024-004 | Significant Deficiency | - | L |
| 365451 | 2024 | 2025-09-03 | 575405 | 2024-004 | Significant Deficiency | - | L |
| 365451 | 2024 | 2025-09-03 | 575404 | 2024-004 | Significant Deficiency | - | L |
| 365451 | 2024 | 2025-09-03 | 575403 | 2024-004 | Significant Deficiency | - | L |
| 365451 | 2024 | 2025-09-03 | 575402 | 2024-004 | Significant Deficiency | - | L |
| 365451 | 2024 | 2025-09-03 | 575401 | 2024-003 | Significant Deficiency | Yes | I |
| 365451 | 2024 | 2025-09-03 | 575400 | 2024-003 | Significant Deficiency | Yes | I |
| 365451 | 2024 | 2025-09-03 | 575399 | 2024-003 | Significant Deficiency | Yes | I |
| 365451 | 2024 | 2025-09-03 | 575398 | 2024-003 | Significant Deficiency | Yes | I |
| 365451 | 2024 | 2025-09-03 | 575397 | 2024-003 | Significant Deficiency | Yes | I |
| 321699 | 2023 | 2024-09-27 | 1075341 | 2023-004 | Material Weakness | - | B |
| 321699 | 2023 | 2024-09-27 | 1075340 | 2023-004 | Material Weakness | - | B |
| 321699 | 2023 | 2024-09-27 | 1075339 | 2023-004 | Material Weakness | - | B |
| 321699 | 2023 | 2024-09-27 | 1075338 | 2023-003 | Significant Deficiency | - | I |
| 321699 | 2023 | 2024-09-27 | 1075337 | 2023-003 | Significant Deficiency | - | I |
| 321699 | 2023 | 2024-09-27 | 1075336 | 2023-003 | Significant Deficiency | - | I |
| 321699 | 2023 | 2024-09-27 | 1075335 | 2023-003 | Significant Deficiency | - | I |
| 321699 | 2023 | 2024-09-27 | 1075334 | 2023-003 | Significant Deficiency | - | I |
| 321699 | 2023 | 2024-09-27 | 1075333 | 2023-003 | Significant Deficiency | - | I |
| 321699 | 2023 | 2024-09-27 | 498899 | 2023-004 | Material Weakness | - | B |
| 321699 | 2023 | 2024-09-27 | 498898 | 2023-004 | Material Weakness | - | B |
| 321699 | 2023 | 2024-09-27 | 498897 | 2023-004 | Material Weakness | - | B |
| 321699 | 2023 | 2024-09-27 | 498896 | 2023-003 | Significant Deficiency | - | I |
| 321699 | 2023 | 2024-09-27 | 498895 | 2023-003 | Significant Deficiency | - | I |
| 321699 | 2023 | 2024-09-27 | 498894 | 2023-003 | Significant Deficiency | - | I |
| 321699 | 2023 | 2024-09-27 | 498893 | 2023-003 | Significant Deficiency | - | I |
| 321699 | 2023 | 2024-09-27 | 498892 | 2023-003 | Significant Deficiency | - | I |
| 321699 | 2023 | 2024-09-27 | 498891 | 2023-003 | Significant Deficiency | - | I |